JNJ-1013

For research use only. Not for therapeutic Use.

  • CAT Number: I041174
  • CAS Number: 2597343-08-1
  • Molecular Formula: C46H55N9O7S
  • Molecular Weight: 878.05
  • Purity: ≥95%
Inquiry Now

JNJ-1013(Cat No.:I041174)is a promising investigational compound developed by Johnson & Johnson, targeting specific molecular pathways in cancer cells. As a small molecule inhibitor, JNJ-1013 works by selectively interfering with the activity of proteins that drive tumor cell proliferation, survival, and metastasis. It is being studied for its potential to treat various solid tumors and hematologic malignancies, particularly in cases where traditional therapies have limited efficacy. Ongoing clinical trials are focused on evaluating its safety, tolerability, and effectiveness, with the aim of providing a new therapeutic option for cancer patients.


CAS Number 2597343-08-1
Synonyms

N-[4-[4-[2-[[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethoxy]piperidin-1-yl]-2-methoxyphenyl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide

Molecular Formula C46H55N9O7S
Purity ≥95%
IUPAC Name N-[4-[4-[2-[[(2S)-1-[(2S,4R)-4-hydroxy-2-[[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]carbamoyl]pyrrolidin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-2-oxoethoxy]piperidin-1-yl]-2-methoxyphenyl]-6-(1H-pyrazol-5-yl)pyridine-2-carboxamide
InChI InChI=1S/C46H55N9O7S/c1-27(29-10-12-30(13-11-29)41-28(2)47-26-63-41)49-44(59)38-23-32(56)24-55(38)45(60)42(46(3,4)5)52-40(57)25-62-33-17-20-54(21-18-33)31-14-15-36(39(22-31)61-6)51-43(58)37-9-7-8-34(50-37)35-16-19-48-53-35/h7-16,19,22,26-27,32-33,38,42,56H,17-18,20-21,23-25H2,1-6H3,(H,48,53)(H,49,59)(H,51,58)(H,52,57)/t27-,32+,38-,42+/m0/s1
InChIKey MHRNVFQJUUXQIG-VIFUUBRESA-N
SMILES CC1=C(SC=N1)C2=CC=C(C=C2)[C@H](C)NC(=O)[C@@H]3C[C@H](CN3C(=O)[C@H](C(C)(C)C)NC(=O)COC4CCN(CC4)C5=CC(=C(C=C5)NC(=O)C6=CC=CC(=N6)C7=CC=NN7)OC)O

Request a Quote